OpenArc Corporate Advisory’s Insmed INSM Stock Holding History

OpenArc Corporate Advisory’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,334	Closed	-$218K	–	814
2026 Q1	$218K	Buy	+1,334	New	+$205K	﹤0.01%	655

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

OpenArc Corporate Advisory's INSM Position: Q2 2026 in Review

OpenArc Corporate Advisory sold out of Insmed (INSM) in Q2 2026, closing a stake of 1,334 shares — an estimated $218K sold.

OpenArc Corporate Advisory first reported a position in INSM in Q1 2026 and held it in 1 quarter. The position peaked at $218K in Q1 2026. 664 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

OpenArc Corporate Advisory reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
OpenArc Corporate Advisory sold 1,334 Insmed shares in Q2 2026, an estimated $218K.
OpenArc Corporate Advisory first reported a position in Insmed in Q1 2026 and held it in 1 quarter.
OpenArc Corporate Advisory's Insmed position peaked at $218K in Q1 2026.
664 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.